- Home
- BTE vs TNGX Comparison
BTE vs TNGX Comparison
Compare BTE & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTE
- TNGX
- Stock Information
- Founded
- BTE 1993
- TNGX 2014
- Country
- BTE Canada
- TNGX United States
- Employees
- BTE N/A
- TNGX N/A
- Industry
- BTE Meat/Poultry/Fish
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- BTE Consumer Staples
- TNGX Health Care
- Exchange
- BTE Nasdaq
- TNGX Nasdaq
- Market Cap
- BTE N/A
- TNGX 735.0M
- IPO Year
- BTE N/A
- TNGX N/A
- Fundamental
- Price
- BTE $2.93
- TNGX $7.15
- Analyst Decision
- BTE Hold
- TNGX Strong Buy
- Analyst Count
- BTE 1
- TNGX 8
- Target Price
- BTE $5.50
- TNGX $15.14
- AVG Volume (30 Days)
- BTE 13.9M
- TNGX 902.1K
- Earning Date
- BTE 10-31-2024
- TNGX 11-06-2024
- Dividend Yield
- BTE 2.24%
- TNGX N/A
- EPS Growth
- BTE N/A
- TNGX N/A
- EPS
- BTE N/A
- TNGX N/A
- Revenue
- BTE $2,504,372,923.00
- TNGX $42,509,000.00
- Revenue This Year
- BTE $43.36
- TNGX $18.15
- Revenue Next Year
- BTE N/A
- TNGX N/A
- P/E Ratio
- BTE N/A
- TNGX N/A
- Revenue Growth
- BTE 67.59
- TNGX 26.16
- 52 Week Low
- BTE $2.85
- TNGX $6.33
- 52 Week High
- BTE $4.65
- TNGX $13.01
- Technical
- Relative Strength Index (RSI)
- BTE 38.66
- TNGX 42.73
- Support Level
- BTE $2.86
- TNGX $6.83
- Resistance Level
- BTE $3.05
- TNGX $7.47
- Average True Range (ATR)
- BTE 0.09
- TNGX 0.35
- MACD
- BTE -0.02
- TNGX 0.14
- Stochastic Oscillator
- BTE 11.02
- TNGX 72.25
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.